The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
Open accessAbstract
Summary Antibodies protect against homologous Dengue virus (DENV) infection but can precipitate severe dengue by promoting heterotypic virus entry via Fcγ receptors (FcγR). We immortalized memory B cells from individuals after primary or secondary infection and analyzed anti-DENV monoclonal antibodies (mAbs) thus generated. MAbs to envelope (E) protein domain III (DIII) were either serotype specific or cross-reactive and potently neutralized DENV infection. DI/DII- or viral membrane protein prM-reactive mAbs neutralized poorly and showed broad cross-reactivity with the four DENV serotypes. All mAbs enhanced infection at subneutralizing concentrations. Three mAbs targeting distinct epitopes on the four DENV serotypes and engineered to prevent FcγR binding did not enhance infection and neutralized DENV in vitro and in vivo as postexposure therapy in a mouse model of lethal DENV infection. Our findings reveal an unexpected degree of cross-reactivity in human antibodies against DENV and illustrate the potential for an antibody-based therapy to control severe dengue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995) · Nature · doi:10.1038/375291a0 · Cited by 1,437
Self-citationTiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,107
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Gibbons, R. V., & Vaughn, D. W. (2002) · BMJ · doi:10.1136/bmj.324.7353.1563 · Cited by 783
Neutralization and Antibody-Dependent Enhancement of Dengue Viruses
Halstead, S. B. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)60011-4 · Cited by 739
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
Self-citationProspects for a dengue virus vaccine
Whitehead, S. S., Blaney, J. E., Durbin, A. P., & Murphy, B. R. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1690 · Cited by 623
Self-citationKliks, S. C., Nimmanitya, S., Nisalak, A., & Burke, D. S. (1988) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.411 · Cited by 578
Proteolytic activation of tick-borne encephalitis virus by furin
Stadler, K., Allison, S. L., Schalich, J., & Heinz, F. X. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8475-8481.1997 · Cited by 561
Young, P. R., Hilditch, P. A., Bletchly, C., & Halloran, W. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1053-1057.2000 · Cited by 542
Self-citationDevelopment of a humanized monoclonal antibody with therapeutic potential against West Nile virus
Oliphant, T., Engle, M., Nybakken, G. E., Doane, C., Johnson, S., Huang, L., Gorlatov, S., Mehlhop, E., Marri, A., Chung, K. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1240 · Cited by 514
Self-citationLethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
Balsitis, S. J., Williams, K. L., Lachica, R., Flores, D., Kyle, J. L., Mehlhop, E., Johnson, S., Diamond, M. S., Beatty, P. R., & Harris, E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000790 · Cited by 412
Self-citationGoncalvez, A. P., Engle, R. E., St. Claire, M., Purcell, R. H., & Lai, C.-J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703498104 · Cited by 364
Dengue: defining protective versus pathologic immunity
Rothman, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421512 · Cited by 364
Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors
van den Broek, M. F., Müller, U., Huang, S., Aguet, M., & Zinkernagel, R. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4792-4796.1995 · Cited by 363
Zellweger, R. M., Prestwood, T. R., & Shresta, S. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.01.004 · Cited by 338
Lai, C.-Y., Tsai, W.-Y., Lin, S.-R., Kao, C.-L., Hu, H.-P., King, C.-C., Wu, H.-C., Chang, G.-J., & Wang, W.-K. (2008) · Journal of Virology · doi:10.1128/jvi.00316-08 · Cited by 326
Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.
Halstead, S. B. (1970) · PubMed · Cited by 320
The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
Pierson, T. C., Xu, Q., Nelson, S., Oliphant, T., Nybakken, G. E., Fremont, D. H., & Diamond, M. S. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.03.002 · Cited by 308
Self-citationMonoclonal Antibody Mapping of the Envelope Glycoprotein of the Dengue 2 Virus, Jamaica
Roehrig, J. T., Bolin, R. A., & Kelly, R. G. (1998) · Virology · doi:10.1006/viro.1998.9200 · Cited by 307
Oliphant, T., Nybakken, G. E., Engle, M., Xu, Q., Nelson, C. A., Sukupolvi-Petty, S., Marri, A., Lachmi, B.-E., Olshevsky, U., Fremont, D. H., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01732-06 · Cited by 306
Self-citationLocalization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes
Crill, W. D., & Chang, G.-J. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13975-13986.2004 · Cited by 300
The growth and potential of human antiviral monoclonal antibody therapeutics
Marasco, W. A., & Sui, J. (2007) · Nature Biotechnology · doi:10.1038/nbt1363 · Cited by 284
Dengue Hemorrhagic Fever in Infants: A Study of Clinical and Cytokine Profiles
Hung, N. T., Lei, H., Lan, N. T., Lin, Y., Huang, K., Lien, L. B., Lin, C., Yeh, T., Ha, D. Q., Huong, V. T. Q., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/380762 · Cited by 282
Wahala, W. M. P. B., Kraus, A. A., Haymore, L. B., Accavitti-Loper, M. A., & de Silva, A. M. (2009) · Virology · doi:10.1016/j.virol.2009.06.037 · Cited by 274
Self-citationImmature Dengue Virus: A Veiled Pathogen?
Rodenhuis-Zybert, I. A., van der Schaar, H. M., da Silva Voorham, J. M., van der Ende-Metselaar, H., Lei, H.-Y., Wilschut, J., & Smit, J. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000718 · Cited by 268
Sukupolvi-Petty, S., Austin, S. K., Purtha, W. E., Oliphant, T., Nybakken, G. E., Schlesinger, J. J., Roehrig, J. T., Gromowski, G. D., Barrett, A. D., Fremont, D. H., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00432-07 · Cited by 263
Self-citationBeasley, D. W. C., & Barrett, A. D. T. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13097-13100.2002 · Cited by 257
Chung, K. M., Nybakken, G. E., Thompson, B. S., Engle, M. J., Marri, A., Fremont, D. H., & Diamond, M. S. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1340-1351.2006 · Cited by 241
Self-citationShrestha, B., Brien, J. D., Sukupolvi-Petty, S., Austin, S. K., Edeling, M. A., Kim, T., O'Brien, K. M., Nelson, C. A., Johnson, S., Fremont, D. H., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000823 · Cited by 208
Self-citationHenchal, E. A., Burke, D. S., Brandt, W. E., McCown, J. M., & Seguin, M. C. (1985) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1985.34.162 · Cited by 199
Chau, T. N. B., Quyen, N. T. H., Thuy, T. T., Tuan, N. M., Hoang, D. M., Dung, N. T. P., Lien, L. B., Quy, N. T., Hieu, N. T., Hieu, L. T. M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590117 · Cited by 186
Self-citationHuang, K.-J., Yang, Y.-C., Lin, Y.-S., Huang, J.-H., Liu, H.-S., Yeh, T.-M., Chen, S.-H., Liu, C.-C., & Lei, H.-Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2825 · Cited by 171
Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus
Oliphant, T., Nybakken, G. E., Austin, S. K., Xu, Q., Bramson, J., Loeb, M., Throsby, M., Fremont, D. H., Pierson, T. C., & Diamond, M. S. (2007) · Journal of Virology · doi:10.1128/jvi.00643-07 · Cited by 171
Self-citationGromowski, G. D., Barrett, N. D., & Barrett, A. D. T. (2008) · Journal of Virology · doi:10.1128/jvi.00606-08 · Cited by 170
Schlesinger, J. J., Foltzer, M. A., & Chapman, S. (1993) · Virology · doi:10.1006/viro.1993.1015 · Cited by 163
Zwick, M. B., Wang, M., Poignard, P., Stiegler, G., Katinger, H., Burton, D. R., & Parren, P. W. H. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12198-12208.2001 · Cited by 160
Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization
Kraus, A., Messer, W. B., Haymore, L. B., & de Silva, A. M. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00827-07 · Cited by 148
The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry
Chin, J. F. L., Chu, J. J. H., & Ng, M. L. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.09.009 · Cited by 148
Bhardwaj, S., Holbrook, M. R., Shope, R. E., Barrett, A. D. T., & Watowich, S. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.4002-4007.2001 · Cited by 145
Characterization of neutralizing antibodies to West Nile virus
Sánchez, M. D., Pierson, T. C., McAllister, D. J., Hanna, S. L., Puffer, B. A., Valentine, L. E., Murtadha, M., Hoxie, J. A., & Doms, R. W. (2005) · Virology · doi:10.1016/j.virol.2005.02.020 · Cited by 138
Gould, L. H., Sui, J., Foellmer, H. G., Oliphant, T., Wang, T., Ledizet, M., Murakami, A., Noonan, K. M., Lambeth, C., Kar, K., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14606-14613.2005 · Cited by 125
Self-citationChau, T. N. B., Hieu, N. T., Anders, K. L., Wolbers, M., Lien, L. B., Hieu, L. T. M., Hien, T. T., Hùng, N. T., Farrar, J., Whitehead, S. S., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/648407 · Cited by 125
Self-citationFalconar, A. K. I. (1999) · Archives of Virology · doi:10.1007/s007050050646 · Cited by 116
Mehlhop, E., Nelson, S., Jost, C. A., Gorlatov, S. N., Johnson, S., Fremont, D. H., Diamond, M., & Pierson, T. C. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.09.003 · Cited by 112
Self-citationSchieffelin, J. S., Costin, J. M., Nicholson, C. O., Orgeron, N. M., Fontaine, K. A., Isern, S., Michael, S. F., & Robinson, J. E. (2010) · Virology Journal · doi:10.1186/1743-422x-7-28 · Cited by 103
Vogt, M. R., Moesker, B., Goudsmit, J., Jongeneelen, M. A. C., Austin, S. K., Oliphant, T., Nelson, S., Pierson, T. C., Wilschut, J., Throsby, M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00286-09 · Cited by 101
Self-citationGoncalvez, A. P., Chien, C.-H., Tubthong, K., Gorshkova, I. I., Roll, C. A., Donau, O. K., Schuck, P., Yoksan, S., Wang, S., Purcell, R. H., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00291-08 · Cited by 75
Falconar, A. K. I. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00371-06 · Cited by 64
Goncalvez, A. P., Men, R., Wernly, C., Purcell, R. H., & Lai, C. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12910-12918.2004 · Cited by 42
Simonelli, L., Beltramello, M., Yudina, Z., Macagno, A., Calzolai, L., & Varani, L. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.12.053 · Cited by 36
Self-citation
Cited by
Dengue: a continuing global threat
Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., et al. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2460 · Cited by 2,082
Self-citationAntibody-dependent enhancement of severe dengue disease in humans
Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G., Gordon, A., Balmaseda, A., & Harris, E. (2017) · Science · doi:10.1126/science.aan6836 · Cited by 1,205
Self-citationModified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Self-citationBeyond binding: antibody effector functions in infectious diseases
Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.106 · Cited by 825
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
Rothman, A. L. (2011) · Nature Reviews Immunology · doi:10.1038/nri3014 · Cited by 770
Metadata
- Authors
- Beltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P. R., de Silva, A. M., Rey, F. A., Varani, L., Whitehead, S. S., Diamond, M. S., Harris, E., Lanzavecchia, A., & Sallusto, F.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 8
- Issue
- 3
- Pages
- 271-283
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2051298245
- Cited by
- 592
- References
- 52
- FWCI
- 33.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.